Company Filing History:
Years Active: 2017
Title: Raimund Peter: Innovator in Pharmaceutical Chemistry
Introduction
Raimund Peter is a notable inventor based in Wilmslow, GB. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that modulate serotonin receptors. With a total of 2 patents to his name, his work has implications for treating various medical conditions.
Latest Patents
Raimund Peter's latest patents include innovative compounds such as substituted [1,4]diazepino[6,7,1-ij]quinolines, which serve as serotonin 5-HT2C receptor modulators. This invention relates to a compound of formula (I) that is useful for modulating the 5-HT receptor, potentially aiding in the prevention and treatment of conditions that respond to this modulation. Additionally, he has developed hexahydrodiazepinoquinolines carrying a substituted alkyl radical, which are also aimed at modulating the 5-HT receptor and preparing medicaments for related disorders.
Career Highlights
Throughout his career, Raimund Peter has worked with prominent companies in the pharmaceutical industry, including AbbVie Deutschland GmbH and Co. KG. His experience in these organizations has allowed him to refine his expertise in drug development and innovation.
Collaborations
Raimund has collaborated with several professionals in his field, including Gisela Backfisch and Margaretha Henrica Maria Bakker. These collaborations have contributed to the advancement of his research and the successful development of his patented inventions.
Conclusion
Raimund Peter's contributions to pharmaceutical chemistry through his innovative patents highlight his role as a significant inventor in the field. His work continues to influence the development of treatments for various medical conditions.